This publication was developed as the outcome of the workshop "Countermeasure R&D: Global Norms for Financing Risk Reduction, Resilience and Equity" which took place on 18 and 19 January 2022. Co-Convenors of the workshop: Government of Norway, Government of Mexico, Global Health Centre at the Graduate Institute of Geneva, and Drugs for Neglected Diseases initiative.
